Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Halothane | hsa00071 | Fatty acid degradation | 2.52E-02 | 3 | O75521, P11766, P33121 | ECI2, ADH5, ACSL1 | More | | Halothane | hsa00220 | Arginine biosynthesis | 3.52E-02 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Halothane | hsa00230 | Purine metabolism | 3.71E-02 | 4 | Q13370, P36959, Q13956, P27707 | PDE3B, GMPR, PDE6H, DCK | More | | Halothane | hsa00250 | Alanine, aspartate and glutamate metabolism | 3.52E-02 | 2 | P49448, P15104 | GLUD2, GLUL | More | | Halothane | hsa00310 | Lysine degradation | 3.52E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Halothane | hsa00380 | Tryptophan metabolism | 4.14E-02 | 1 | Q16613 | AANAT | More | | Halothane | hsa00500 | Starch and sucrose metabolism | 1.07E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Halothane | hsa00562 | Inositol phosphate metabolism | 1.44E-02 | 4 | P27987, Q13572, P19174, P42338 | ITPKB, ITPK1, PLCG1, PIK3CB | More | | Halothane | hsa00630 | Glyoxylate and dicarboxylate metabolism | 8.71E-07 | 2 | P40925, P15104 | MDH1, GLUL | More | | Halothane | hsa00730 | Thiamine metabolism | 8.96E-04 | 3 | Q9Y6K8, P05186, P24666 | AK5, ALPL, ACP1 | More | | Halothane | hsa00760 | Nicotinate and nicotinamide metabolism | 3.52E-02 | 1 | P21589 | NT5E | More | | Halothane | hsa00770 | Pantothenate and CoA biosynthesis | 2.27E-02 | 2 | O95498, O95497 | VNN2, VNN1 | More | | Halothane | hsa00910 | Nitrogen metabolism | 3.52E-02 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Halothane | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.77E-04 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | | Halothane | hsa01100 | Metabolic pathways | 3.52E-02 | 23 | P05089, O95455, P21953, P32320, P11766, P06280, Q16875, O43286, O43451, P05186, P24666, Q9HCC0, P33121, Q08477, P15907, Q9UNP4, P37837, P32321, Q9BPW9, Q9UHY7, P43490, P46976, P06737 | ARG1, TGDS, BCKDHB, CDA, ADH5, GLA, PFKFB3, B4GALT5, MGAM, ALPL, ACP1, MCCC2, ACSL1, CYP4F3, ST6GAL1, ST3GAL5, TALDO1, DCTD, DHRS9, ENOPH1, PBEF1, GYG1, PYGL | More | | Halothane | hsa03008 | Ribosome biogenesis in eukaryotes | 4.94E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | | Halothane | hsa03013 | RNA transport | 1.13E-02 | 8 | P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, Q9Y6A5 | NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, TACC3 | More | | Halothane | hsa03022 | Basal transcription factors | 2.17E-02 | 3 | P20226, O00268, Q15544 | TBP, TAF4, TAF11 | More | | Halothane | hsa03040 | Spliceosome | 3.11E-02 | 7 | O60508, P08579, Q13595, P84103, P11142, O43447, O75643 | CDC40, SNRPB2, TRA2A, SFRS3, HSPA8, PPIH, ASCC3L1 | More | | Halothane | hsa03050 | Proteasome | 1.40E-02 | 1 | P55036 | PSMD4 | More | | Halothane | hsa03430 | Mismatch repair | 3.21E-02 | 2 | P43246, P15927 | MSH2, RPA2 | More | | Halothane | hsa04012 | ErbB signaling pathway | 1.44E-02 | 4 | P16333, Q13191, P19174, P42338 | NCK1, CBLB, PLCG1, PIK3CB | More | | Halothane | hsa04020 | Calcium signaling pathway | 6.05E-04 | 8 | P27987, P21796, P30679, O15399, P19174, P0DP23, P23634, P49767 | ITPKB, VDAC1, GNA15, GRIN2D, PLCG1, CALM1, ATP2B4, VEGFC | More | | Halothane | hsa04024 | cAMP signaling pathway | 3.37E-02 | 3 | P63092, P26678, P61586 | GNAS, PLN, RHOA | More | | Halothane | hsa04060 | Cytokine-cytokine receptor interaction | 4.71E-02 | 2 | P78552, O75509 | IL13RA1, TNFRSF21 | More | | Halothane | hsa04062 | Chemokine signaling pathway | 2.21E-02 | 8 | P25024, P19875, P07948, P42338, P19174, P63218, P50151, P43250 | CXCR1, CXCL2, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6 | More | | Halothane | hsa04070 | Phosphatidylinositol signaling system | 2.82E-02 | 3 | P0DP23, Q16760, Q96PE3 | CALM1, DGKD, INPP4A | More | | Halothane | hsa04072 | Phospholipase D signaling pathway | 7.71E-04 | 5 | Q92529, P61586, O14986, Q14344, P63092 | SHC3, RHOA, PIP5K1B, GNA13, GNAS | More | | Halothane | hsa04120 | Ubiquitin mediated proteolysis | 6.89E-03 | 5 | Q14145, Q13042, Q13191, Q15751, Q7Z6Z7 | KEAP1, CDC16, CBLB, HERC1, HUWE1 | More | | Halothane | hsa04137 | Mitophagy - animal | 2.52E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | | Halothane | hsa04144 | Endocytosis | 4.40E-02 | 6 | Q13191, P11142, P25024, P43250, P14784, Q9Y5X3 | CBLB, HSPA8, CXCR1, GRK6, IL2RB, SNX5 | More | | Halothane | hsa04150 | mTOR signaling pathway | 2.23E-02 | 3 | P42338, Q13322, P49841 | PIK3CB, GRB10, GSK3B | More | | Halothane | hsa04151 | PI3K-Akt signaling pathway | 2.09E-03 | 11 | P42338, P43657, P49767, P08238, P63218, P50151, P13612, O15335, Q13751, P14784, P30279 | PIK3CB, P2RY5, VEGFC, HSP90AB1, GNG5, GNG10, ITGA4, CHAD, LAMB3, IL2RB, CCND2 | More | | Halothane | hsa04213 | Longevity regulating pathway - multiple species | 4.29E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Halothane | hsa04310 | Wnt signaling pathway | 4.17E-03 | 3 | P61586, P19784, P67870 | RHOA, CSNK2A2, CSNK2B | More | | Halothane | hsa04380 | Osteoclast differentiation | 4.80E-02 | 4 | P06239, P42338, P14778, Q8N149 | LCK, PIK3CB, IL1R1, LILRA2 | More | | Halothane | hsa04510 | Focal adhesion | 6.16E-03 | 10 | P13612, P42338, O14986, P12814, P61586, O15335, Q16363, Q13751, P30279, P49767 | ITGA4, PIK3CB, PIP5K1B, ACTN1, RHOA, CHAD, LAMA4, LAMB3, CCND2, VEGFC | More | | Halothane | hsa04520 | Adherens junction | 1.38E-04 | 3 | P19784, P67870, P61586 | CSNK2A2, CSNK2B, RHOA | More | | Halothane | hsa04621 | NOD-like receptor signaling pathway | 2.70E-03 | 10 | Q16539, P10599, Q9H1Y0, P43490, O00463, P01375, P09341, P59665, P59666, P12838 | MAPK14, TXN, ATG5, PBEF1, TRAF5, TNF, CXCL1, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Halothane | hsa04657 | IL-17 signaling pathway | 1.03E-02 | 6 | O00463, Q16539, P49841, P09341, P14780, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, TNF | More | | Halothane | hsa04658 | Th1 and Th2 cell differentiation | 1.86E-03 | 7 | P07766, P20963, P19174, P06239, Q9UL17, P14784, Q13761 | CD3E, CD247, PLCG1, LCK, TBX21, IL2RB, RUNX3 | More | | Halothane | hsa04659 | Th17 cell differentiation | 4.57E-05 | 9 | P19174, P06239, P14784, P14778, Q9UL17, Q13485, P08238, P07766, P20963 | PLCG1, LCK, IL2RB, IL1R1, TBX21, SMAD4, HSP90AB1, CD3E, CD247 | More | | Halothane | hsa04660 | T cell receptor signaling pathway | 4.18E-03 | 8 | P42338, P19174, P16333, P07766, P20963, Q13191, P06239, O43318 | PIK3CB, PLCG1, NCK1, CD3E, CD247, CBLB, LCK, MAP3K7 | More | | Halothane | hsa04662 | B cell receptor signaling pathway | 1.26E-03 | 6 | P49841, P42338, P60033, P07948, P21854, Q8N149 | GSK3B, PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Halothane | hsa04664 | Fc epsilon RI signaling pathway | 1.44E-02 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Halothane | hsa04670 | Leukocyte transendothelial migration | 2.88E-02 | 6 | P13612, P11215, P42338, P19174, Q15669, P12814 | ITGA4, ITGAM, PIK3CB, PLCG1, RHOH, ACTN1 | More | | Halothane | hsa04713 | Circadian entrainment | 4.94E-02 | 2 | P62873, P63092 | GNB1, GNAS | More | | Halothane | hsa04723 | Retrograde endocannabinoid signaling | 4.94E-02 | 2 | P48169, P62873 | GABRA4, GNB1 | More | | Halothane | hsa04724 | Glutamatergic synapse | 2.48E-04 | 6 | O15399, P63092, P62873, P63218, P50151, P15104 | GRIN2D, GNAS, GNB1, GNG5, GNG10, GLUL | More | | Halothane | hsa04726 | Serotonergic synapse | 2.52E-02 | 2 | P63092, P62873 | GNAS, GNB1 | More | | Halothane | hsa04730 | Long-term depression | 3.52E-02 | 1 | Q14344 | GNA13 | More | | Halothane | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.24E-03 | 4 | P14778, P19174, P42338, P24723 | IL1R1, PLCG1, PIK3CB, PRKCH | More | | Halothane | hsa04926 | Relaxin signaling pathway | 3.63E-03 | 6 | P42338, P63218, P50151, P49767, P30679, P49407 | PIK3CB, GNG5, GNG10, VEGFC, GNA15, ARRB1 | More | | Halothane | hsa04929 | GnRH secretion | 3.63E-02 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | | Halothane | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Halothane | hsa04960 | Aldosterone-regulated sodium reabsorption | 4.38E-02 | 1 | P48048 | KCNJ1 | More | | Halothane | hsa04964 | Proximal tubule bicarbonate reclamation | 3.52E-02 | 2 | P49448, P40925 | GLUD2, MDH1 | More | | Halothane | hsa04972 | Pancreatic secretion | 3.65E-02 | 2 | P63092, P61586 | GNAS, RHOA | More | | Halothane | hsa04973 | Carbohydrate digestion and absorption | 4.12E-03 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Halothane | hsa05017 | Spinocerebellar ataxia | 2.09E-03 | 4 | Q92915, O15399, P42338, P21796 | FGF14, GRIN2D, PIK3CB, VDAC1 | More | | Halothane | hsa05032 | Morphine addiction | 4.42E-05 | 9 | P62873, P63218, P50151, P48169, P78334, P63092, P32298, P43250, P49407 | GNB1, GNG5, GNG10, GABRA4, GABRE, GNAS, GRK4, GRK6, ARRB1 | More | | Halothane | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.22E-03 | 7 | Q16539, P09341, P19875, P19174, P25024, P25025, P07948 | MAPK14, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2, LYN | More | | Halothane | hsa05135 | Yersinia infection | 3.13E-02 | 5 | P13612, P06239, P19174, O43318, P42338 | ITGA4, LCK, PLCG1, MAP3K7, PIK3CB | More | | Halothane | hsa05140 | Leishmaniasis | 1.32E-03 | 9 | P13612, O75015, P14598, O60603, P01375, P29350, P49006, Q16539, Q15080 | ITGA4, FCGR3B, NCF1, TLR2, TNF, PTPN6, MARCKSL1, MAPK14, NCF4 | More | | Halothane | hsa05142 | Chagas disease | 2.26E-02 | 3 | P01375, P30679, P48023 | TNF, GNA15, FASLG | More | | Halothane | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | | Halothane | hsa05146 | Amoebiasis | 3.18E-05 | 11 | Q13751, P09341, P19875, P14778, P27930, P01375, P42338, P11215, P05089, P30679, P12814 | LAMB3, CXCL1, CXCL2, IL1R1, IL1R2, TNF, PIK3CB, ITGAM, ARG1, GNA15, ACTN1 | More | | Halothane | hsa05150 | Staphylococcus aureus infection | 1.83E-02 | 3 | P59665, P59666, P12838 | DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Halothane | hsa05162 | Measles | 2.06E-02 | 7 | P14784, P07766, P42338, P11142, Q13191, P30279, O43318 | IL2RB, CD3E, PIK3CB, HSPA8, CBLB, CCND2, MAP3K7 | More | | Halothane | hsa05163 | Human cytomegalovirus infection | 3.51E-04 | 16 | P42338, P01375, P62873, P63218, P50151, Q14344, P61586, P49841, P14778, Q13651, P25025, Q16539, P63092, O00463, P30101, P61769 | PIK3CB, TNF, GNB1, GNG5, GNG10, GNA13, RHOA, GSK3B, IL1R1, IL10RA, CXCR2, MAPK14, GNAS, TRAF5, PDIA3, B2M | More | | Halothane | hsa05166 | Human T-cell leukemia virus 1 infection | 4.02E-02 | 10 | P14784, P30279, P21796, Q13485, Q13042, P14778, P07766, P42338, P06239, P06746 | IL2RB, CCND2, VDAC1, SMAD4, CDC16, IL1R1, CD3E, PIK3CB, LCK, POLB | More | | Halothane | hsa05169 | Epstein-Barr virus infection | 1.57E-02 | 9 | Q13547, O43318, P42338, P07948, P30101, Q13761, P30279, P07766, P20963 | HDAC1, MAP3K7, PIK3CB, LYN, PDIA3, RUNX3, CCND2, CD3E, CD247 | More | | Halothane | hsa05170 | Human immunodeficiency virus 1 infection | 3.76E-02 | 8 | P42338, P63218, P50151, P30101, O43318, P19174, P07766, P20963 | PIK3CB, GNG5, GNG10, PDIA3, MAP3K7, PLCG1, CD3E, CD247 | More | | Halothane | hsa05171 | Coronavirus disease - COVID-19 | 4.47E-02 | 2 | Q9UHA3, O14786 | RSL24D1, NRP1 | More | | Halothane | hsa05200 | Pathways in cancer | 1.51E-02 | 15 | Q13751, P42338, P08238, P19174, P43246, Q13485, Q13547, P30279, P49767, P43657, P63218, P50151, Q14344, P78417, P14784 | LAMB3, PIK3CB, HSP90AB1, PLCG1, MSH2, SMAD4, HDAC1, CCND2, VEGFC, P2RY5, GNG5, GNG10, GNA13, GSTO1, IL2RB | More | | Halothane | hsa05225 | Hepatocellular carcinoma | 1.85E-02 | 2 | Q92529, P51531 | SHC3, SMARCA2 | More | | Halothane | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.03E-02 | 5 | P42338, P19174, P07766, P20963, P06239 | PIK3CB, PLCG1, CD3E, CD247, LCK | More | | Halothane | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Halothane | hsa05332 | Graft-versus-host disease | 3.70E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Halothane | hsa05418 | Fluid shear stress and atherosclerosis | 2.43E-03 | 7 | Q16539, P42338, P10599, P14780, P01375, P14778, P27930 | MAPK14, PIK3CB, TXN, MMP9, TNF, IL1R1, IL1R2 | More | | |